Nuro Pharma, Inc.
Manufacturer Details
There are currently no manufacturer details available.
Nuro Pharma, Inc. Drugs
-
![Glycate (Glycopyrrolate) Tablet [Nuro Pharma, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=045baa49-d22c-4ed8-8dd6-b90565eca017&name=045baa49-d22c-4ed8-8dd6-b90565eca017-02.jpg)
Glycate
The dosage of Glycopyrrolate Tablets, USP should be adjusted to the needs of the individual patient to assure symptomatic controlwith a minimum of adverse reactions. The presently recommended maximum daily dosage of glycopyrrolate is 8 mg.
Glycopyrrolate Tablets, USP 1 mg. The recommended initial dosage of Glycopyrrolate 1 mg tablets for adults is one tablet three times daily (in the morning, early afternoon, and at bedtime). Some patients may require two tablets at bedtime to assure overnight control of symptoms.
For maintenance, a dosage of one tablet twice a day is frequently adequate.
Glycopyrrolate Tablets, USP 2 mg. The recommended dosage of Glycopyrrolate 2 mg tablets for adults is one tablet two or three times daily at equally spaced intervals.
Glycopyrrolate Tablets, USP 1.5 mg. The Glycopyrrolate 1.5 mg tablets may be used to provide intermediate titration doses based on response of the patient.
Glycopyrrolate Tablets, USP are not recommended for use in pediatric patients under the age of 12 years.
-
![Doral (Quazepam) Tablet [Nuro Pharma, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=81aaf61f-0185-440a-9540-c4f873d5e7eb&name=doral-02.jpg)
Doral
Use the lowest dose effective for the patient, as important adverse effects of DORAL are dose related.
The recommended initial dose is 7.5 mg. The 7.5 mg dose can be increased to 15 mg if necessary for efficacy.
The 7.5 mg dose can be achieved by splitting the 15 mg tablet along the score line.
2.1 Special Populations
Elderly and debilitated patients may be more sensitive to benzodiazepines.
Sign Up for a Free Account